K3 Pharma Private Limited
About K3 Pharma Private Limited
Data last updated:
K3 Pharma Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 12 July 2022.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24230UP2022PTC167434.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anjily Satyam and Sunil Kumar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 13/385 Ratan Orchid Civil Lines, Kanpur, Uttar Pradesh, India – 208001.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.23 Lakh, a growth of 147% compared to the previous year. For the same year it recorded a net profit of ₹16,907 (net margin 4%) and EBITDA of ₹22,607 (EBITDA margin 5.3%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address13/385 Ratan Orchid Civil Lines, Kanpur, Uttar Pradesh, India – 208001
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of K3 Pharma Private Limited
The main business activity of K3 Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of K3 Pharma Private Limited FY 2025 filings available
K3 Pharma Private Limited reported revenue of ₹4.23 Lakh (up 147% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of K3 Pharma Private Limited
Revenue rose 147% in the latest year. EBITDA rose 54% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of K3 Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹22,607 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹16,907 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of K3 Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 5.3% | •••• |
| Net Profit Margin | 4% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of K3 Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of K3 Pharma Private Limited
K3 Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Indigreen Eco Technologies Private Limited | ₹4.24 Lakh (FY 2018) | •••• | •••• | -92.0% | •••• | Secunderabad, Telangana, India |
| Twist Business Bioplast & Environmental Safety Private Limited | ₹4.24 Lakh (FY 2020) | •••• | •••• | •••• | Kollam, Kerala, India | |
| Somac Healthcare Private Limited | ₹4.24 Lakh (FY 2025) | •••• | •••• | -29.0% | •••• | Chennai, Tamil Nadu, India |
| Ebullition Pharmaceuticals Private Limited | ₹4.23 Lakh (FY 2022) | •••• | •••• | -46.0% | •••• | New Delhi, Delhi, India |
| Prochesta Farmers Producer Company Limited | ₹4.23 Lakh (FY 2024) | •••• | •••• | -35.0% | •••• | Morigaon, Assam, India |
| K3 Pharma Private Limited this company | ₹4.23 Lakh (FY 2024) | •••• | •••• | 147.0% | •••• | Kanpur, Uttar Pradesh, India |
| Weiin Marketing Private Limited | ₹4.23 Lakh (FY 2019) | •••• | •••• | -58.0% | •••• | Ranchi, Jharkhand, India |
| Ambesten Electricals Private Limited | ₹4.23 Lakh (FY 2025) | •••• | •••• | -94.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Panchshree Vanijya Private Limited | ₹4.23 Lakh (FY 2017) | •••• | •••• | -34.0% | •••• | Kolkata, West Bengal, India |
| A1shine Cleaning & Hygiene Products Private Limited | ₹4.23 Lakh (FY 2025) | •••• | •••• | -19.0% | •••• | Mumbai, Maharashtra, India |
| Aril Life Sciences Private Limited | ₹4.23 Lakh (FY 2023) | •••• | •••• | -9.0% | •••• | Patna, Bihar, India |
Peers are the five companies nearest above and the five nearest below K3 Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of K3 Pharma Private Limited
K3 Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjily Satyam | Director | 12 Jul 2022 | 4 Years 2 Months | Current |
| Sunil Kumar Gupta | Director | 12 Jul 2022 | 4 Years 2 Months | Current |
Charges & Borrowings of K3 Pharma Private Limited
K3 Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at K3 Pharma Private Limited
Employment history and EPFO contributions of people linked to K3 Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on K3 Pharma Private Limited
K3 Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Anjily Satyam was appointed as Director on 12 Jul 2022.
Credit Ratings, Litigation & Regulatory Alerts for K3 Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by K3 Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of K3 Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of K3 Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of K3 Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about K3 Pharma Private Limited
K3 Pharma is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 12 July 2022 (4+ years old) and is registered under CIN U24230UP2022PTC167434.
K3 Pharma reported revenue of ₹4.23 Lakh for FY 2024 (up 147% YoY).
K3 Pharma has 2 current directors:
- Anjily Satyam - Director
- Sunil Kumar Gupta - Director
K3 Pharma reported a net profit of ₹16,907 (net margin 4%) and EBITDA of ₹22,607 (EBITDA margin 5.3%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of K3 Pharma is U24230UP2022PTC167434. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
K3 Pharma was incorporated on 12 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of K3 Pharma by revenue are Indigreen Eco Technologies Private Limited, Twist Business Bioplast & Environmental Safety Private Limited, Somac Healthcare Private Limited, Ebullition Pharmaceuticals Private Limited, Prochesta Farmers Producer Company Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Anjily Satyam was appointed as Director on 12 Jul 2022. Sunil Kumar Gupta was appointed as Director on 12 Jul 2022.
The registered office of K3 Pharma is at 13385 Ratan Orchid Civil Lines, Kanpur, Uttar Pradesh, India – 208001.
K3 Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
K3 Pharma operates in the chemicals industry, in the manufacturing segment.